Neurocrine Biosciences Inc
NBIX
$141.37-0.75%
End of day · as of Oct 12, 2026, 8:00 PM ET
Mkt cap
$13.21B
EV/Sales
4.37
P/E ratio
N/A
FY2025 Revenue
$2.86B
EPS (TTM)
$6.84
Gross Margin (FY2025)
98.18%
Profit Margin (FY2025)
16.73%
Beta
0.24
Div yield
N/A
Sector
Healthcare
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NBIX revenue for 2025-12-31 was $2.86B. Net income was $478.6M. Revenue was up 21.4% from 2024-12-31 to 2025-12-31. NBIX currently screens at market cap $13.21B.
Use this NBIX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NBIX income, balance, and cash tables.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Neurocrine Biosciences Inc (NBIX) revenue for Dec 31, 2025 was $2.86B. Net income was $478.6M. Statements: https://lician.com/financials/nbix
Neurocrine Biosciences Inc (NBIX) market capitalization is $13.21B on the latest cached snapshot.
Neurocrine Biosciences Inc (NBIX) cached previous close $142.44; day range $141.37 – $142.37; volume 1,081,559. Session quote: https://lician.com/quote/nbix
Neurocrine Biosciences Inc (NBIX) latest cached earnings event is "NBIX earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NBIX filing is 8-K · Sep 28, 2026. Filings: https://lician.com/sec/nbix